.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
UBS
AstraZeneca
Express Scripts
Colorcon
US Army
Federal Trade Commission
Covington
Cerilliant

Generated: June 23, 2017

DrugPatentWatch Database Preview

Halobetasol propionate - Generic Drug Details

« Back to Dashboard

What are the generic sources for halobetasol propionate and what is the scope of halobetasol propionate patent protection?

Halobetasol propionate
is the generic ingredient in two branded drugs marketed by Fougera Pharms, G And W Labs Inc, G And W Labs, Perrigo Israel, Taro, Sun Pharm Inds Ltd, Ranbaxy, and Sun Pharm Inds, and is included in twelve NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Halobetasol propionate has fourteen patent family members in fourteen countries.

There are nine drug master file entries for halobetasol propionate. Nine suppliers are listed for this compound.

Summary for Generic Name: halobetasol propionate

Tradenames:2
Patents:2
Applicants:8
NDAs:12
Drug Master File Entries: see list9
Suppliers / Packagers: see list9
Bulk Api Vendors: see list38
Clinical Trials: see list335
Patent Applications: see list3,163
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Drug Prices:see low prices
DailyMed Link:halobetasol propionate at DailyMed

Pharmacology for Ingredient: halobetasol propionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro
HALOBETASOL PROPIONATE
halobetasol propionate
OINTMENT;TOPICAL076994-001Dec 16, 2004ABRXNoNo► Subscribe► Subscribe
G And W Labs
HALOBETASOL PROPIONATE
halobetasol propionate
OINTMENT;TOPICAL077721-001Sep 7, 2006ABRXNoNo► Subscribe► Subscribe
Fougera Pharms
HALOBETASOL PROPIONATE
halobetasol propionate
CREAM;TOPICAL077001-001Dec 16, 2004ABRXNoNo► Subscribe► Subscribe
Taro
HALOBETASOL PROPIONATE
halobetasol propionate
CREAM;TOPICAL077227-001Aug 4, 2005ABRXNoNo► Subscribe► Subscribe
Perrigo Israel
HALOBETASOL PROPIONATE
halobetasol propionate
OINTMENT;TOPICAL076872-001Dec 16, 2004ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: halobetasol propionate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds Ltd
ULTRAVATE
halobetasol propionate
CREAM;TOPICAL019967-001Dec 27, 19904,619,921► Subscribe
Ranbaxy
ULTRAVATE
halobetasol propionate
OINTMENT;TOPICAL019968-001Dec 17, 19904,619,921► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: halobetasol propionate

Country Document Number Estimated Expiration
African Regional IP Organization (ARIPO)201508420► Subscribe
South Korea20150069005► Subscribe
World Intellectual Property Organization (WIPO)2014062817► Subscribe
Singapore11201502931Y► Subscribe
India4160DEN2015► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
AstraZeneca
Daiichi Sankyo
Express Scripts
Queensland Health
Citi
Colorcon
Fuji
Teva
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot